- Home
- » Tags
- » Blonanserin
Top View
- National Institute for Health and Care Excellence Surveillance Programme
- Okumura Et Al. 27
- Ceritinib: Drug Information
- “REAL World Data” Using RDB and Hadoop
- Sumitomo Dainippon Pharma to Launch Atypical Antipsychotic ® LONASEN Tape in Japan
- Blonanserin Ameliorates Phencyclidine-Induced Visual-Recognition Memory Deficits: the Complex Mechanism of Blonanserin Action In
- Quetiapine-Related Weight Loss: Report of a Rare Adverse Effect
- Current Concepts and Treatments of Schizophrenia
- Subjective Response to Antipsychotics in Bipolar Disorders
- Report on Investigation Results
- Inhibitory Effects of Antipsychotics on the Contractile Response To
- Treatment of Antipsychotic-Induced Hyperprolactinemia: an Update on the Role of the Dopaminergic Receptors D2 Partial Agonist Aripiprazole
- Augmentation with Blonanserin for a Schizophrenia Patient with Insufficient Response to Clozapine
- 2016.04 Atypical Antipsychotic Agents Drug Class Review.Pdf
- Switching Antipsychotics to Blonanserin in Patients with Schizophrenia: an Open-Label, Prospective, Multicenter Study
- Pharmaceuticals and Medical Devices Safety Information No
- Fluvoxamine for Blonanserin-Associated Akathisia In
- Blonanserin Ameliorates Social Deficit Through Dopamine-D3 Receptor
- Blonanserin – a Novel Antianxiety and Antidepressant Drug? An
- Dopamine, Cognitive Impairments and Second-Generation Antipsychotics: from Mechanistic Advances to More Personalized Treatments
- Blonanserin Induced Hypokinesia and Tardive Dyskinesia
- Efficacy and Safety of Blonanserin Transdermal Patch in Patients with Schizophrenia: a 6-Week Randomized, Double-Blind, Placebo- Controlled, Multicenter Study
- Blonanserin-Induced Mood Alteration in Schizophrenia and Schizoaffective Disorder: Two Cases
- Nbn Glossary שתי טבלאות
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Update on New and Emerging Treatments for Schizophrenia
- Two Cases of Blonanserin Induced Dyskinesia 1Dhananjay Chaudhari, 2Ganesh Shanker, 3Kunjan Gupta
- Amisulpride in Refractory Behavioral and Psychological Symptoms of Dementia
- A 52-Week, Randomized, Open-Label Study of Aripiprazole Versus
- Medications Associated with Geriatric Syndrome (MAGS) and Their Prevalence in Older Hospitalized Adults Discharged to Skilled Nursing Facilities
- Clinical Benefit and Utility of Switching to Aripiprazole Once Monthly In